ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Propensity-matched comparison of mortality between peritoneal dialysis and hemodialysis in patients with type 2 diabetes

Liu, Hui; He, Zhiren; Hu, Xiaoxuan; Li, Shaoxue; Wang, Lixin; Zhao, Daixin; Lin, Qizhan; Liu, Xusheng; Lu, Fuhua*; Zhang, Difei*广东省人民医院; 广州中医药大学
INTERNATIONAL UROLOGY AND NEPHROLOGY2022-6DOI: 10.1007/s11255-021-03026-y
2被引9阅读
引用收藏
分享

摘要

Background The optimal choice of dialysis modality for diabetic patients remains controversial. This study aimed to compare mortality between peritoneal dialysis (PD) and hemodialysis (HD) in end-stage renal disease (ESRD) patients with type 2 diabetes (T2D). Methods Our observational, longitudinal cohort consisted of all incident ESRD patients with T2D who received either PD or HD in our center from January 2012 to December 2017 and were followed until December 2019. Propensity scores were used to select a 1:1 matched cohort. Mortality was compared between dialysis modalities using Kaplan-Meier survival analysis, and risk factors for mortality were estimated using multivariate Cox regression analyses. Results The median follow-up times were 35.5 months in the PD group (n = 134) and 41.6 months in the HD group (n = 134, p = 0.0381). The 1-, 2-, 3-, 5-, and 7-year patient survival rates were 98%, 91%, 77%, 61%, and 35% for diabetic PD patients and 96%, 88%, 81%, 60%, and 57% for diabetic HD patients. Kaplan-Meier survival analysis showed that overall mortality did not significantly differ between modalities (log-rank = 0.9473, p = 0.6575). Using a multivariate Cox regression model, advanced age and increased cholesterol at the initiation of PD treatment were independent risk factors associated with mortality, whereas under HD therapy, the risk factors associated with mortality were lower BMI and higher HbA1c. Conclusions These results suggest that in patients with T2D, mortality is comparable between PD and HD irrespective of whether there are the first 2 years or over the 2-year period, and that different mortality predictor patterns exist between patients treated with PD versus HD.

学科与关键词

关键词
Type 2 diabetesPeritoneal dialysisHemodialysisMortalityRisk factors
相关
加载中…
  • Coexistence of diabetes mellitus and pre-existing cardiovascular disease and mortality in Chinese patients on peritoneal dialysis
    Lei, Guangtao; Feng, Xiaoran; Wang, Xiaoyang; Wen, Yueqiang; Peng, FenFen; Wang, Niansong; Zhan, Xiaojiang; Wu, Qinghua*; Wu, Xianfeng*BMC Nephrology, 2022, 23(1): 68.被引 2
  • Impact of dialysis modality choice on the survival of end-stage renal disease patients with congestive heart failure in southern China: A retrospective cohort study
    He, Zhiren; Liang, Hui; Huang, Jing; Zhang, Defei; Ma, Hongyan; Lin, Junjie; Cai, Youqing; Liu, Tonghuan; Li, Hucai; Qiu, Weizhong; Wang, Lingzheng; Yuan, Fengling; Hou, Haijing; Zhao, Daixin; Liu, Xusheng*; Wang, Lixin*Frontiers in Medicine, 2022, 9: 898650.
  • Burden of kidney disease among patients with peritoneal dialysis versus conventional in-centre haemodialysis: A randomised, non-inferiority trial
    Fan, Li; Yang, Xiao; Chen, Qinkai; Zhang, Hao; Wang, Jianqin; Chen, Menghua; Peng, Hui; Ni, Zhaohui; Wan, Jianxin; Yang, Hongtao; Li, Yun; Wang, Li; Peng, Ai; Lin, Hongli; Zhang, Jinyuan; Shen, Huaying; Xiong, Fei; He, Yongcheng; Zha, Yan; Xie, Minyan; Jiao, Jundong; Jiang, Gengru; Zheng, Xunhuan; Xiao, Jun; Rong, Rong; Qian, Jiaqi; Yu, Xueqing*Peritoneal Dialysis International, 2022, 42(3): 246-258.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
INTERNATIONAL UROLOGY AND NEPHROLOGY
发表日期
2022-06
卷期
第 54 卷, 第 6 期
页码
1373-1381
DOI
10.1007/s11255-021-03026-y
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Inheritance and Innovation of Traditional Chinese Medicine platform construction for Nephropathy [01030315]; Project of Administration of Traditional Chinese Medicine of Guangdong Province of China [20192028]

作者

  • L

    Liu, Hui (第一作者)

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • H

    He, Zhiren

    guangdong prov hosp

查看全部 10 位作者收起作者
  • H

    Hu, Xiaoxuan

    guangdong prov hosp

  • L

    Li, Shaoxue

    guangdong prov hosp

  • W

    Wang, Lixin

    guangdong prov hosp

  • Z

    Zhao, Daixin

    guangdong prov hosp

  • L

    Lin, Qizhan

    guangdong prov hosp

  • L

    Liu, Xusheng

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • L

    Lu, Fuhua (通讯)

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • Z

    Zhang, Difei (通讯)

    2 · guangzhou univ chinese med · guangdong prov hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417